Martin Langanke - Böcker
Visar alla böcker från författaren Martin Langanke. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
1 636 kr
Skickas inom 10-15 vardagar
In 2009 the University Medicine Greifswald launched the “Greifswald Approach to Individualized Medicine” (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes – next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients – chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the Germanhealth care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.
1 589 kr
Skickas inom 10-15 vardagar
In 2009 the University Medicine Greifswald launched the “Greifswald Approach to Individualized Medicine” (GANI_MED) to implement biomarker-based individualized diagnostic and therapeutic strategies in clinical settings. Individualized Medicine (IM) has led not only to controversies about its potentials, but also about its societal, ethical and health economic implications. This anthology focusses on these areas and includes – next to clinical examples illustrating how the integrated analysis of biomarkers leads to significant improvement of therapeutic outcomes for a subgroup of patients – chapters about the definition, history and epistemology of IM. Additionally there is a focus on conceptual philosophical questions as well as challenges for applied research ethics (informed consent process, the IT-based consent management and the handling of incidental findings). Finally it pays attention to health economic aspects. The possibilities of IM to initiate a paradigm shift in the Germanhealth care provision are investigated. Furthermore, it is asked whether the G-DRG system is ready for the implementation of such approaches into clinical routine.
Zufallsbefunde bei molekulargenetischen Untersuchungen
Medizinische, juristische und ethische Perspektiven
Inbunden, Tyska, 2015
616 kr
Skickas inom 10-15 vardagar
Durch neuartige und verbesserte Methoden zur molekulargenetischen Diagnostik kommt es immer häufiger zum Problem der genetischen „Zufallsbefunde“ (oder besser: Zusatzbefunde). Darunter versteht man Befunde oder Auffälligkeiten, die unabhängig von der ursprünglichen medizinischen Fragestellung oder aus wissenschaftlichen Studien heraus entstehen, jedoch Bedeutung für die Gesundheit und Familienplanung der untersuchten Person sowie ihrer leiblichen Verwandten haben können.Die Beiträge des Buches entstammen einer vom Bundeministerium für Bildung und Forschung geförderten Fachtagung an der Ernst-Moritz-Arndt-Universität Greifswald und widmen sich den vielfältigen medizinischen, juristischen und ethischen Herausforderungen, die zu bedenken sind, wenn in Versorgung und Forschung mit der Möglichkeit genetischer Zufallsbefunde gerechnet werden muss.